This article explains how GSK is using machine learning to increase R&D productivity and accelerating drug development timelines.
Can open innovation speed the drug discovery pipeline?
Pfizer is using Bitcoin technology to prevent counterfeit drug sales. Who will pay the cost for the digital supply blockchain? Will Pfizer expand its own B2C ecommerce?
Faced with increased price and regulatory pressures, the pharma industry is forced to look to other avenues for revenue growth, including digitilization of its historically unwieldy and heavily regulated supply chains. Is industry leader Pfizer doing enough in this pursuit?
A digitized supply chain in pharma has unfortunately failed to mitigate the growing opioid crisis in America. Can it and will it?
How the "Internet of Things" is impacting the pharma industry
Forget self-driving cars – Merck looks to create a self-driving supply chain with artificial intelligence calling the shots
As drug pricing policies dominate pharmaceutical headlines, the threat of economic nationalism looms even larger over AstraZeneca’s R&D pipeline.
What will digital success in the pharmaceutical industry look like 10 years from now? What are the right initiatives to capture the digital opportunity? How well will a giant pharmaceutical company implement changes in the digital landscape? One Chicago pharmaceutical company AbbVie, is currently in a unique position to lead the sluggish pharma industry’s transformation into the digital age. (734 words)
Finding growth, repositioning the business and being nimble in the dynamic pharma environment